Publicaciones en colaboración con investigadores/as de Helsinki University Central Hospital (7)

2024

  1. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    The Lancet Haematology, Vol. 11, Núm. 2, pp. e147-e159

  2. Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation

    Journal of Infectious Diseases, Vol. 229, Núm. 1, pp. 83-94

2021

  1. Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study

    Bone Marrow Transplantation, Vol. 56, Núm. 5, pp. 1171-1179

2020

  1. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    The Lancet Haematology, Vol. 7, Núm. 2, pp. e157-e167

2019

  1. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

    The Lancet Haematology, Vol. 6, Núm. 2, pp. e89-e99

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2016

  1. Antilymphocyte globulin for prevention of chronic graft-versus-host disease

    New England Journal of Medicine, Vol. 374, Núm. 1, pp. 43-53